AEPCX
Price
$57.74
Change
-$0.23 (-0.40%)
Updated
Jun 3 closing price
Net Assets
133.25B
FITGX
Price
$21.60
Change
+$0.15 (+0.70%)
Updated
Jun 2 closing price
Net Assets
6.51B
Interact to see
Advertisement

AEPCX vs FITGX

Header iconAEPCX vs FITGX Comparison
Open Charts AEPCX vs FITGXBanner chart's image
American Funds Europacific Growth C
Price$57.74
Change-$0.23 (-0.40%)
VolumeN/A
Net Assets133.25B
Fidelity Advisor International Growth M
Price$21.60
Change+$0.15 (+0.70%)
VolumeN/A
Net Assets6.51B
AEPCX vs FITGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. FITGX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and FITGX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. FITGX (6.51B). AEPCX pays higher dividends than FITGX: AEPCX (0.32) vs FITGX (0.00). AEPCX was incepted earlier than FITGX: AEPCX (24 years) vs FITGX (18 years). AEPCX (1.59) is less costly to investors than FITGX (1.40). FITGX (31.00) and AEPCX (30.00) have comparable annual turnover. FITGX annual gain was more profitable for investors over the last year : 6.40 vs. AEPCX (1.80). FITGX return over 5 years is better than : 39.38 vs. AEPCX (15.20).
AEPCXFITGXAEPCX / FITGX
Total Expense Ratio1.591.40114%
Annual Report Gross Expense Ratio1.591.40114%
Fund Existence24 years18 years-
Gain YTD11.7489.607122%
Front LoadN/A4%-
Min. Initial Investment250N/A-
Min. Initial Investment IRAN/AN/A-
Net Assets133B6.51B2,045%
Annual Yield % from dividends0.320.00-
Returns for 1 year1.806.4028%
Returns for 3 years14.7230.6348%
Returns for 5 years15.2039.3839%
Returns for 10 years19.4484.4423%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELTX8.080.33
+4.26%
Elicio Therapeutics
MBC10.200.38
+3.87%
MasterBrand
IOVA1.820.06
+3.41%
Iovance Biotherapeutics
VIVS1.770.02
+1.43%
VivoSim Lab Inc
SNN29.12-0.03
-0.10%
Smith & Nephew plc